Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "66619067161afa2274ff4f3b",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Metformin SR 850mg",
"description": "SEIZMET SR 850 \nMetformin SR (850mg) \nIntroduction to SEIZMET SR 850\nSEIZMET SR 850 contains Metformin Hydrochloride 850mg in a sustained-release (SR) formulation. This medication is primarily used for the management of type 2 diabetes mellitus. Metformin belongs to a class of drugs known as biguanides, which help control blood sugar levels by improving the body's response to insulin. The sustained-release formulation ensures a prolonged effect throughout the day, providing steady glycemic control.\n\nWhat is Metformin?\nOverview of Metformin\nMetformin is an oral diabetes medication that helps lower blood sugar levels by improving insulin sensitivity and reducing glucose production in the liver. It also enhances glucose uptake and utilization in peripheral tissues, making it an effective treatment for type 2 diabetes.\n\nMechanism of Action\nInsulin Sensitization: Metformin works by decreasing hepatic glucose production and increasing insulin sensitivity in peripheral tissues, allowing cells to absorb glucose more effectively.\nGlucose Uptake: By enhancing insulin sensitivity, Metformin helps muscles and adipose tissues take up glucose from the bloodstream, lowering blood sugar levels.\nReduced Glucose Production: Metformin decreases the amount of glucose produced by the liver, contributing to overall glycemic control.\nBenefits of SEIZMET SR 850\nEffective Blood Sugar Management\nImproved Insulin Sensitivity: SEIZMET SR 850 helps improve the body's response to insulin, leading to better control of blood sugar levels.\nComprehensive Glycemic Control: By targeting both insulin sensitivity and hepatic glucose production, Metformin provides a unique mechanism of action that complements other diabetes medications, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: SEIZMET SR 850 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, SEIZMET SR 850 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Neutral or Loss: Unlike some other diabetes medications, Metformin is often associated with weight neutrality or modest weight loss, making it a favorable option for overweight or obese patients.\nCardiovascular Benefits: Metformin has been shown to have beneficial effects on cardiovascular health, reducing the risk of heart disease and stroke in patients with type 2 diabetes.\nHow to Use SEIZMET SR 850\nDosage and Administration\nRecommended Dosage: The typical dosage of SEIZMET SR 850 is one tablet taken once daily with the evening meal. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take SEIZMET SR 850 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/seizmet-sr-850-133444",
"price": 43.0,
"discountamount": 13.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"day",
"body",
"Diet",
"cells",
"class",
"Order",
"EMAIL",
"drugs",
"water",
"meals",
"liver",
"amount",
"Action",
"stroke",
"option",
"Support",
"muscles",
"readings",
"Overview",
"biguanides",
"full glass",
"one tablet",
"neuropathy",
"overweight",
"Guidelines",
"bloodstream",
"utilization",
"information",
"retinopathy",
"Optimal Use",
"Adjustments",
"Metformin SR",
"Introduction",
"sterispharma",
"Reduced Risk",
"best results",
"evening meal",
"sterisonline",
"heart disease",
"CALL/WHATSAPP",
"SEIZMET SR 850",
"glucose uptake",
"Consistent Use",
"Administration",
"Weight Neutral",
"obese patients",
"typical dosage",
"treatment plan",
"unique mechanism",
"Exercise Adjunct",
"prolonged effect",
"excellent adjunct",
"Recommended Dosage",
"modest weight loss",
"peripheral tissues",
"beneficial effects",
"blood sugar control",
"individual response",
"Diabetes Management",
"effective treatment",
"healthcare provider",
"insulin sensitivity",
"cardiovascular health",
"Insulin Sensitization",
"cardiovascular disease",
"Metformin Hydrochloride",
"steady glycemic control",
"Cardiovascular Benefits",
"long-term complications",
"lifestyle modifications",
"type 2 diabetes mellitus",
"overall glycemic control",
"oral diabetes medication",
"stable blood sugar levels",
"Reduced Glucose Production",
"Additional Health Benefits",
"hepatic glucose production",
"other diabetes medications",
"gastrointestinal discomfort",
"sustained-release formulation",
"Comprehensive Glycemic Control",
"Effective Blood Sugar Management",
"sustained-release (SR) formulation",
"comprehensive blood sugar management"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1451,
"imageuri": "https://productimages.withfloats.com/actual/66619068c06ee12d88cfeb92.jpg",
"tileimageuri": "https://productimages.withfloats.com/tile/66619068c06ee12d88cfeb92.jpg",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-06T10:33:11.434Z",
"updatedon": "2026-03-13T06:30:27.801Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/metformin-sr-850mg/1451",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "SEIZMET SR 850 ",
"category": "DIABETIC RANGE",
"tags": [
"SEIZMET SR 850",
"Metformin SR (850mg)",
"Glycomet 850 SR in pregnancy",
"Glycomet SR 850 composition",
"Glycomet SR 850 side effects",
"Metformin 850 mg price",
"Glycomet 850 SR uses"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "666185c2161afa2274ff4d10",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Glimepiride, Metformin SR , and Pioglitazone",
"description": "SEIZMET GP 2 \nGlimepiride (2 mg), Metformin SR (500mg), Pioglitazone (15mg)\nIntroduction to SEIZMET GP 2\nSEIZMET GP 2 is a combination medication that includes Glimepiride 2 mg, Metformin Hydrochloride Sustained Release (SR) 500mg, and Pioglitazone 15mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Glimepiride, Metformin, and Pioglitazone, SEIZMET GP 2 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Glimepiride, Metformin, and Pioglitazone?\nOverview of Glimepiride\nGlimepiride is a sulfonylurea that helps control blood sugar levels by stimulating the pancreas to release more insulin. It works by closing ATP-sensitive potassium channels in the pancreatic beta cells, leading to insulin secretion.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nOverview of Pioglitazone\nPioglitazone is a thiazolidinedione (TZD) that helps improve blood sugar control by increasing the body's sensitivity to insulin. It works by activating PPARγ (peroxisome proliferator-activated receptor gamma) receptors, which regulate the transcription of insulin-responsive genes involved in the control of glucose and lipid metabolism.\n\nBenefits of SEIZMET GP 2\nEffective Blood Sugar Management\nTriple Mechanism of Action: Glimepiride stimulates insulin secretion, Metformin improves insulin sensitivity and reduces hepatic glucose production, and Pioglitazone enhances insulin sensitivity in peripheral tissues, providing a comprehensive approach to glycemic control.\nPostprandial and Fasting Glucose Control: This combination helps manage both postprandial (after-meal) and fasting blood sugar levels, offering all-around glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: SEIZMET GP 2 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, SEIZMET GP 2 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Metformin is often associated with weight neutrality or modest weight loss, making it a favorable option for overweight or obese patients.\nLipid Profile Improvement: Pioglitazone can improve lipid profiles by lowering triglycerides and increasing HDL cholesterol levels, offering additional cardiovascular benefits.\nHow to Use SEIZMET GP 2\nDosage and Administration\nRecommended Dosage: The typical dosage of SEIZMET GP 2 is one tablet taken once or twice daily, depending on your healthcare provider's instructions. The dosage may be adjusted based on individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin and Pioglitazone. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take SEIZMET GP 2 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\n",
"price": 154.0,
"discountamount": 46.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"day",
"TZD",
"body",
"meal",
"Diet",
"Order",
"EMAIL",
"liver",
"PPARγ",
"water",
"amount",
"Action",
"option",
"Support",
"pancreas",
"Overview",
"readings",
"biguanide",
"overweight",
"one tablet",
"Guidelines",
"neuropathy",
"full glass",
"retinopathy",
"utilization",
"information",
"Optimal Use",
"Adjustments",
"Introduction",
"best results",
"SEIZMET GP 2",
"Pioglitazone",
"Metformin SR",
"sterisonline",
"Reduced Risk",
"Postprandial",
"instructions",
"sterispharma",
"sulfonylurea",
"triglycerides",
"effectiveness",
"CALL/WHATSAPP",
"transcription",
"Administration",
"obese patients",
"typical dosage",
"lipid profiles",
"treatment plan",
"Consistent Use",
"Glimepiride 2mg",
"lipid metabolism",
"Exercise Adjunct",
"prolonged effect",
"Triple Mechanism",
"weight neutrality",
"thiazolidinedione",
"excellent adjunct",
"Weight Management",
"insulin secretion",
"peripheral tissues",
"modest weight loss",
"Recommended Dosage",
"healthcare provider",
"individual response",
"blood sugar control",
"insulin sensitivity",
"Diabetes Management",
"pancreatic beta cells",
"HDL cholesterol levels",
"combination medication",
"cardiovascular disease",
"comprehensive approach",
"Fasting Glucose Control",
"long-term complications",
"lifestyle modifications",
"complementary mechanisms",
"insulin-responsive genes",
"type 2 diabetes mellitus",
"Lipid Profile Improvement",
"peripheral glucose uptake",
"stable blood sugar levels",
"hepatic glucose production",
"Additional Health Benefits",
"gastrointestinal discomfort",
"sustained-release formulation",
"comprehensive glycemic control",
"ATP-sensitive potassium channels",
"Effective Blood Sugar Management",
"additional cardiovascular benefits",
"Metformin Hydrochloride Sustained Release",
"peroxisome proliferator-activated receptor gamma) receptors"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1443,
"imageuri": "https://productimages.withfloats.com/actual/666185c5c06ee12d88cfaefd.png",
"tileimageuri": "https://productimages.withfloats.com/tile/666185c5c06ee12d88cfaefd.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-06T09:47:46.414Z",
"updatedon": "2026-03-13T06:29:28.725Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//glimepiride-metformin-sr-and-pioglitazone/1443",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "SEIZMET GP 2 ",
"category": "DIABETIC RANGE",
"tags": [
"SEIZMET GP 2",
"Glimepiride (2mg)",
"Metformin SR (500mg)",
"Pioglitazone (15mg)",
"Pioglitazone side effects",
"Pioglitazone 15 mg price",
"Side effects of pioglitazone 15 mg",
"Is pioglitazone safe",
"Pioglitazone uses"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6ad74702e53c888beeab308d",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliozin 10 mg, Sitagliptin 100 mg and Metformin hydrochloride 1000 mg ER Tablets",
"description": "GLIEMPAFLOZIN 3D 10 is a triple-combination antidiabetic tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This combination is intended for the management of type 2 diabetes mellitus in appropriately selected patients under the supervision of a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help regulate blood glucose levels. Empagliflozin helps the kidneys eliminate glucose through urine, Sitagliptin supports glucose-dependent insulin regulation, and Metformin helps reduce glucose production in the liver while improving insulin sensitivity.\n\nBy combining these ingredients in one tablet, GLIEMPAFLOZIN 3D 10 provides a multi-mechanism approach to blood glucose management. Its suitability depends on the patient's clinical condition, kidney function, existing treatment, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 10\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 10 mg: A sodium-glucose cotransporter 2 (SGLT2) inhibitor that reduces glucose reabsorption by the kidneys and increases glucose excretion through urine.\nSitagliptin 100 mg: A dipeptidyl peptidase-4 (DPP-4) inhibitor that helps regulate insulin and glucagon responses according to blood glucose levels.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, approved indications, and administration instructions should be confirmed from the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 10 Tablets\nGLIEMPAFLOZIN 3D 10 combines three established antidiabetic medicines with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: Targets different processes involved in blood glucose regulation.\nExtended-release metformin: Provides a formulation designed to release Metformin gradually over time.\nOral tablet dosage form: Allows administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThe combination is not suitable for every person with diabetes. Treatment decisions should be based on individual medical needs and the approved product information.\n\nUses of GLIEMPAFLOZIN 3D 10\nGLIEMPAFLOZIN 3D 10 is intended for the management of type 2 diabetes mellitus, subject to its approved indications and the prescribing healthcare professional's assessment.\n\nType 2 diabetes is a chronic metabolic condition characterized by impaired insulin action and, in many patients, insufficient insulin production. Persistently elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three active ingredients in GLIEMPAFLOZIN 3D 10 address different aspects of glucose regulation. A healthcare professional may consider this combination when multiple medicines are required to achieve an individual's treatment goals and when the combination is clinically appropriate.\n\nThe medicine should be used as part of a comprehensive diabetes-management plan that may include balanced nutrition, regular physical activity, blood glucose monitoring, and routine medical assessments. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 10 Work?\n1. Empagliflozin 10 mg\nEmpagliflozin belongs to the SGLT2 inhibitor class. It blocks a protein responsible for reabsorbing glucose filtered by the kidneys. This allows more glucose to be eliminated through urine, helping reduce blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. Whether these benefits apply to an individual depends on their clinical condition and the applicable prescribing information.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. By increasing incretin activity, Sitagliptin supports insulin release when blood glucose is elevated and helps regulate glucagon secretion. These actions contribute to blood glucose control.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily reduces glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nTogether, these ingredients target several pathways involved in type 2 diabetes. Their combined effectiveness and safety depend on appropriate prescribing, correct administration, and regular monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 10\nWhen prescribed for an appropriate patient, GLIEMPAFLOZIN 3D 10 may offer the following treatment advantages:\n\nMultiple mechanisms of action: Combines three medicines that influence different aspects of glucose regulation.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nCombination therapy: May simplify a treatment regimen compared with taking the same ingredients as separate tablets.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nPersonalized treatment options: May be considered when a healthcare professional determines that triple therapy is appropriate.\nIndividual outcomes vary, and the medicine does not replace a suitable diet, physical activity, or routine diabetes care.\n\nDirections for Use\nTake GLIEMPAFLOZIN 3D 10 only as prescribed by your healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or your prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or stop treatment without consulting your prescriber.\nAttend recommended appointments for kidney-function assessment and blood glucose monitoring.\nIf you miss a dose, follow the official patient information or ask your healthcare professional or pharmacist what to do. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 10 is a prescription medicine and may not be suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important kidney-related prescribing considerations.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients at risk of dehydration or low blood pressure should discuss appropriate precautions with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin may increase the risk of genital fungal infections and can be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, or excessive alcohol intake.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nHypoglycemia: Low blood glucose may occur, particularly when the combination is used with insulin or insulin secretagogues such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, and upcoming procedures involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 10?\nGLIEMPAFLOZIN 3D 10 brings together Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg in a triple-combination tablet intended for selected patients with type 2 diabetes.\n\nFor pharmaceutical websites, pharmacies, distributors, and healthcare professionals, clear information about composition, mechanism of action, potential uses, and precautions supports responsible product awareness.\n\nAlways refer to the approved product label for the exact composition, indications, dosage, contraindications, storage requirements, and instructions for use.\n\nConclusion\nGLIEMPAFLOZIN 3D 10 Tablets combine Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. The combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 10?\n\nGLIEMPAFLOZIN 3D 10 is a combination tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 10 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom this combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 10 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 10 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 10 suitable for everyone with diabetes?\n\nNo. Suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and approved prescribing information.\n\n",
"price": 210.0,
"discountamount": 147.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2505,
"imageuri": "https://productimages.withfloats.com/actual/6ad7470422551901df6e5493.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad7470422551901df6e5493.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T10:48:34.116Z",
"updatedon": "2026-10-20T10:48:34.116Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//empagliozin-10-mg-sitagliptin-100-mg-and-metformin-hydrochloride-1000-mg-er-tablets/2505",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN 3D 10",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6ad7442bf24c5a4bbccf4b10",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliflozin,Sitagliptin And Metformin Hydrochloride (ER) Tablets",
"description": "GLIEMPAFLOZIN 3D 25 is a combination pharmaceutical product containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This triple-combination formulation is intended for the management of type 2 diabetes mellitus in appropriate patients, as determined by a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help control blood glucose levels. Empagliflozin belongs to the sodium-glucose cotransporter 2 (SGLT2) inhibitor class, Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, and Metformin is a biguanide antidiabetic medicine. Together, these ingredients target different pathways involved in glucose regulation.\n\nGLIEMPAFLOZIN 3D 25 provides a combination of three established antidiabetic agents in a single tablet. Its suitability depends on the patient's blood glucose levels, kidney function, current diabetes treatment, medical history, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 25\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 25 mg: An SGLT2 inhibitor that helps the kidneys remove glucose from the bloodstream through urine.\nSitagliptin 100 mg: A DPP-4 inhibitor that increases the activity of incretin hormones involved in glucose-dependent insulin release and glucagon regulation.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, administration instructions, and approved indications should be verified against the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 25\nGLIEMPAFLOZIN 3D 25 combines three antidiabetic ingredients with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: The ingredients act through different mechanisms involved in blood glucose regulation.\nExtended-release metformin: The ER formulation is designed to release metformin over an extended period.\nOral tablet dosage form: Provides oral administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered by a healthcare professional when combination therapy is appropriate.\nThe benefits of this combination depend on the patient's clinical needs and the suitability of all three ingredients.\n\nUses of GLIEMPAFLOZIN 3D 25 Tablets\nGLIEMPAFLOZIN 3D 25 is intended for the management of type 2 diabetes mellitus, subject to the product's approved indications and the prescribing healthcare professional's judgment.\n\nType 2 diabetes is a chronic metabolic condition in which the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood glucose levels. Long-term elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three medicines in GLIEMPAFLOZIN 3D 25 target different aspects of glucose regulation. A healthcare professional may consider a combination regimen when an individual's treatment goals are not adequately achieved with a simpler regimen or when the combination is otherwise clinically appropriate.\n\nThe medicine should be used alongside an individualized diabetes-management plan that may include a balanced diet, physical activity, glucose monitoring, and regular medical follow-up. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 25 Work?\nThe three active ingredients contribute to blood glucose management through distinct mechanisms.\n\n1. Empagliflozin 25 mg\nEmpagliflozin inhibits SGLT2, a protein responsible for reabsorbing much of the glucose filtered by the kidneys. By reducing glucose reabsorption, it increases glucose excretion through urine and helps lower blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. These benefits depend on the patient's condition and the applicable prescribing information and should not be assumed to apply identically to every patient.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. Increasing incretin activity helps stimulate insulin release when blood glucose is elevated and reduces glucagon secretion when appropriate. This helps regulate glucose levels, particularly after meals.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily decreases glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nBy combining these mechanisms, GLIEMPAFLOZIN 3D 25 targets several pathways involved in type 2 diabetes. Its overall effectiveness and safety depend on appropriate patient selection, dosing, and ongoing monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 25\nWhen prescribed for an appropriate patient, this combination may offer the following treatment advantages:\n\nMultiple mechanisms of action: Addresses glucose regulation through three different pharmacological pathways.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nOral combination therapy: Combines three medicines in one tablet, which may simplify a prescribed regimen compared with taking each ingredient separately.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nIndividualized treatment options: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThese potential advantages do not guarantee a particular result. Treatment effectiveness depends on adherence, diet, physical activity, individual health status, and medical supervision.\n\nDirections for Use\nGLIEMPAFLOZIN 3D 25 should be taken only as prescribed by a qualified healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or discontinue treatment without consulting your prescriber.\nAttend recommended appointments for blood glucose monitoring and kidney-function assessment.\nIf a dose is missed, follow the official patient information or ask your healthcare professional or pharmacist for advice. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 25 is a prescription medicine and is not suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important renal considerations, and the combination may be unsuitable at certain levels of kidney impairment.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients should discuss dehydration risk, low blood pressure, and fluid intake with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin can increase the risk of genital fungal infections and may be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, excessive alcohol intake, or other predisposing conditions.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nLow blood glucose: The risk of hypoglycemia may increase when this combination is used with insulin or insulin secretagogues, such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, or an upcoming medical procedure involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, unusual weakness, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 25?\nGLIEMPAFLOZIN 3D 25 brings together Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER in a triple-combination tablet designed for the management of type 2 diabetes in appropriately selected patients.\n\nFor pharmaceutical product catalogues, distributors, pharmacies, and healthcare professionals, accurate information about the composition, mechanism of action, approved indications, and safety profile supports responsible product awareness.\n\nTreatment decisions should always be based on the patient's medical assessment and the approved product information.\n\nConclusion\nGLIEMPAFLOZIN 3D 25 Tablets combine Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. This combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 25?\n\nGLIEMPAFLOZIN 3D 25 is a combination tablet containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 25 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom the combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 25 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 25 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan as recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 25 suitable for everyone with diabetes?\n\nNo. Its suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and the approved prescribing information.",
"price": 230.0,
"discountamount": 69.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2504,
"imageuri": "https://productimages.withfloats.com/actual/6ad7442d6e565c5fe6e5b7cb.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad7442d6e565c5fe6e5b7cb.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T10:36:27.325Z",
"updatedon": "2026-10-20T10:36:27.325Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//empagliflozin-sitagliptin-and-metformin-hydrochloride-er-tablets/2504",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN 3D 25",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a6dedd85b0d81b5d5e65e09",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Olanzapine Mouth Dissolving Tablets 2.5 mg",
"description": "OLANZPRIME 2.5 is a high-quality pharmaceutical formulation containing Olanzapine 2.5 mg in a convenient mouth dissolving tablet (MDT) dosage form. Developed to support the management of various psychiatric disorders, this formulation is designed to deliver effective therapy while improving patient convenience and treatment adherence. Manufactured in GMP-certified facilities using premium pharmaceutical ingredients, OLANZPRIME 2.5 is produced under strict quality control standards to ensure safety, purity, and consistent performance.\n\nThe rapidly dissolving tablet is formulated to disintegrate quickly on the tongue without the need for water, making it an ideal option for patients who have difficulty swallowing conventional tablets. Its user-friendly dosage form enhances ease of administration while providing dependable therapeutic support under the supervision of a qualified healthcare professional.\n\nComposition\n\nBrand Name: OLANZPRIME 2.5\n\nGeneric Name: Olanzapine\n\nStrength: 2.5 mg\n\nDosage Form: Mouth Dissolving Tablet (MDT)\n\nWhat is OLANZPRIME 2.5?\n\nOLANZPRIME 2.5 contains Olanzapine, an atypical antipsychotic medication that works by regulating the activity of important neurotransmitters such as dopamine and serotonin. By helping restore the balance of these chemical messengers, the medicine supports improved emotional stability, clearer thinking, better behavioral control, and overall mental health.\n\nIts mouth dissolving formulation is specifically designed to provide greater convenience, particularly for individuals who experience difficulty swallowing standard oral tablets.\n\nUses of OLANZPRIME 2.5\n\nOLANZPRIME 2.5 may be recommended by healthcare professionals for the treatment and long-term management of various psychiatric conditions, including:\n\nSchizophrenia\nBipolar disorder, including manic and mixed episodes\nMaintenance therapy for bipolar disorder\nManagement of psychotic symptoms\nSelected behavioral or psychiatric conditions as determined by a physician\n\nThe appropriate dosage and duration of therapy should always be decided by a qualified healthcare provider based on the patient's individual clinical needs.\n\nBenefits of OLANZPRIME 2.5\nQuick-Dissolving Technology\n\nThe tablet dissolves rapidly in the mouth without requiring water, making administration simple and convenient.\n\nImproved Patient Adherence\n\nThe easy-to-take formulation is especially beneficial for elderly patients and individuals with swallowing difficulties, helping improve compliance with prescribed treatment.\n\nProven Antipsychotic Therapy\n\nOlanzapine is a well-established atypical antipsychotic used by healthcare professionals to help manage symptoms associated with schizophrenia and bipolar disorder.\n\nManufactured to High Pharmaceutical Standards\n\nProduced under strict GMP guidelines, OLANZPRIME 2.5 undergoes comprehensive quality testing to ensure consistent safety, efficacy, and product reliability.\n\nConvenient Anytime Administration\n\nThe mouth dissolving dosage form offers flexibility and ease of use, even when drinking water is not readily available.\n\nHow OLANZPRIME 2.5 Works\n\nOlanzapine belongs to the atypical antipsychotic class of medicines. It acts by modulating the activity of dopamine and serotonin receptors in the brain, helping restore a healthy balance of neurotransmitters involved in mood, perception, and behavior.\n\nThis therapeutic action may help reduce symptoms such as:\n\nHallucinations\nDelusional thoughts\nAgitation\nMood fluctuations\nDisorganized thinking\nAnxiety associated with certain psychiatric conditions\n\nWith regular use as prescribed, OLANZPRIME 2.5 helps support mental stability and improves overall quality of life for many patients.\n\nDosage and Administration\n\nTake OLANZPRIME 2.5 exactly as directed by your healthcare professional.\n\nGeneral administration guidelines include:\n\nPlace the tablet directly on the tongue.\nAllow it to dissolve completely before swallowing.\nWater is generally not required.\nTake the medication at the same time each day whenever possible.\nContinue treatment for the duration recommended by your physician.\nDo not stop taking the medicine without medical advice.\nPossible Side Effects\n\nLike all prescription medicines, OLANZPRIME 2.5 may cause side effects in some individuals, although not everyone experiences them.\n\nCommon side effects may include:\n\nDrowsiness\nDizziness\nDry mouth\nIncreased appetite\nWeight gain\nConstipation\nTiredness\n\nSerious or unusual symptoms require prompt medical evaluation. Always consult your healthcare provider if side effects become persistent or concerning.\n\nPrecautions and Warnings\n\nBefore starting OLANZPRIME 2.5, inform your healthcare provider if you have:\n\nDiabetes mellitus\nLiver disorders\nHeart disease\nEpilepsy or seizure disorders\nHigh cholesterol or lipid abnormalities\nHistory of stroke\nKidney impairment\nKnown allergy to Olanzapine or any ingredient in the formulation\n\nAlcohol consumption should generally be avoided during treatment, as it may increase drowsiness and other central nervous system effects.\n\nStorage Instructions\n\nTo preserve product quality:\n\nStore in a cool and dry place.\nProtect from direct sunlight and excessive moisture.\nKeep below the storage temperature mentioned on the product packaging.\nStore in the original blister pack until use.\nKeep out of the reach of children.\nWhy Choose OLANZPRIME 2.5?\n\nOLANZPRIME 2.5 combines trusted antipsychotic therapy with the convenience of mouth dissolving technology, making it an excellent option for patients who require easy administration without compromising treatment effectiveness.\n\nKey Advantages\n\nPremium-quality Olanzapine 2.5 mg formulation\nRapid mouth dissolving tablet for easy administration\nNo water required for consumption\nSupports improved medication compliance\nManufactured under stringent GMP quality standards\nReliable dosage accuracy and product consistency\nSecure packaging designed to maintain product stability\nFrequently Asked Questions (FAQs)\nWhat is OLANZPRIME 2.5 prescribed for?\n\nOLANZPRIME 2.5 is prescribed for the treatment and management of schizophrenia, bipolar disorder, and other psychiatric conditions as determined by a qualified healthcare professional.\n\nDoes this tablet need to be taken with water?\n\nNo. The mouth dissolving tablet is designed to dissolve on the tongue, allowing convenient administration without water.\n\nCan I discontinue OLANZPRIME 2.5 without consulting my doctor?\n\nNo. Treatment should not be stopped suddenly, as abrupt discontinuation may increase the risk of symptom recurrence or withdrawal effects. Always seek medical advice before making any changes to your medication.\n\nIs OLANZPRIME 2.5 appropriate for older adults?\n\nHealthcare professionals may prescribe this medicine for elderly patients when clinically appropriate. Individual dosage adjustments may be necessary depending on the patient's overall health and medical history.\n\nHow long should treatment continue?\n\nThe duration of therapy varies according to the patient's diagnosis, treatment response, and clinical condition. Your healthcare provider will determine the most appropriate treatment plan and monitor progress throughout therapy.",
"price": 60.0,
"discountamount": 18.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2489,
"imageuri": "https://productimages.withfloats.com/actual/6a6deddbc0246085c8f7252b.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a6deddbc0246085c8f7252b.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-08-01T13:00:08.65Z",
"updatedon": "2026-08-01T13:00:08.65Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//olanzapine-mouth-dissolving-tablets-2-5-mg/2489",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "OLANZPRIME 2.5",
"category": "NEUROLOGYRANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a5df5b80932adf55b8b989e",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Olanzapine Mouth Dissolving Tablets 15 mg",
"description": "OLANZPRIME 15 is a mouth-dissolving tablet containing Olanzapine 15 mg, prescribed for schizophrenia and bipolar disorder. As an atypical antipsychotic, it works by rebalancing dopamine and serotonin activity in the brain, easing hallucinations, delusions, mood swings, and disorganized thinking. The dissolving format is built for patients who find swallowing standard tablets difficult, letting the tablet break down on the tongue without water. It's typically taken once daily at a consistent time, under a psychiatrist's supervision, and should never be stopped abruptly. Common effects include drowsiness and appetite changes. Prescription only – consult your doctor.\n\nMeta Title Options (50–60 characters)\nOLANZPRIME 15 Price – Olanzapine MD Tablet | Steris (Recommended)\nOLANZPRIME 15 – Olanzapine Mouth Dissolving Tablet\nOLANZPRIME 15 Price – Schizophrenia & Bipolar Care\nOlanzapine 15mg MD Tablet – OLANZPRIME Price\nOLANZPRIME 15 – Antipsychotic MD Tablet Online\n\nRationale: Option 1 leads with the required “Price” anchor for this Schedule H product, keeps the brand and dosage form searchable, and stays within the 50–60 character target.\n\nMeta Description (140–160 characters)\n\nOLANZPRIME 15 (Olanzapine 15mg MD) eases schizophrenia and bipolar symptoms. Check price online. Prescription only – consult your doctor before use.\n\nFull CMS Article\nOLANZPRIME 15: Olanzapine Mouth Dissolving Tablet for Schizophrenia and Bipolar Disorder\nTL;DR / AI Mode Summary\n\nOLANZPRIME 15 delivers Olanzapine 15 mg in a mouth-dissolving format, used in the treatment of schizophrenia and bipolar disorder. It belongs to the atypical antipsychotic class and acts on dopamine and serotonin pathways to ease hallucinations, delusions, mood instability, and disorganized thought. The dissolving tablet is especially useful for patients — including elderly or psychiatric patients — who struggle with swallowing regular pills. It is a Schedule H medicine and must be taken strictly as prescribed by a psychiatrist.\n\nWhat Is OLANZPRIME 15?\n\nOLANZPRIME 15 is built around Olanzapine, a second-generation (atypical) antipsychotic that psychiatrists prescribe to manage serious mental health conditions. Rather than a standard swallow-with-water tablet, this formulation is designed to break down on the tongue within seconds, which supports better adherence in patients who find conventional dosing forms hard to manage.\n\nComposition at a Glance\nAttribute\tDetail\nBrand Name\tOLANZPRIME 15\nActive Ingredient\tOlanzapine\nStrength\t15 mg\nForm\tMouth Dissolving Tablet (MD)\nTherapeutic Class\tAtypical Antipsychotic\nSchedule Status\tSchedule H – Prescription Only\nCommon Indications\nSchizophrenia\nBipolar I Disorder, including manic episodes\nLong-term maintenance therapy for bipolar disorder\nAcute agitation linked to psychotic episodes, under physician direction\nMood instability requiring antipsychotic support\nOther psychiatric conditions where antipsychotic therapy is indicated\n\nBy calming excess dopamine signaling, this medicine can reduce hallucinations, delusional thinking, and aggression, helping patients function more steadily day to day.\n\nMechanism of Action\n\nPsychiatric symptoms such as hallucinations, delusions, and racing or disorganized thoughts are closely tied to overactive dopamine (D2) signaling in the brain, alongside disruptions in serotonin (5-HT2A) pathways.\n\nOlanzapine works by:\n\nDampening excess dopamine receptor activity\nModulating serotonin receptor signaling\nReducing hallucinations and delusional thought patterns\nSupporting emotional and mood stability\nEasing agitation and aggressive behavior\nImproving focus and social engagement\nSupporting more restful sleep\n\nBecause the tablet dissolves directly in the mouth, it's absorbed without needing water, making it a practical option for elderly patients and those with swallowing difficulty.\n\nDirections for Use\nTake OLANZPRIME 15 only as your psychiatrist prescribes.\nPlace the tablet on the tongue and let it dissolve fully — do not chew.\nSwallow naturally once dissolved; water is generally not needed.\nTake it at the same time each day to build a consistent routine.\nNever stop the medicine abruptly without medical guidance, as sudden discontinuation can trigger withdrawal or relapse symptoms.\nPossible Side Effects\n\nMost side effects are mild and tend to ease as the body adjusts. These can include:\n\nDrowsiness\nDizziness\nIncreased appetite\nWeight gain\nDry mouth\nConstipation\nFatigue\nTremors\nRestlessness\n\nPlaceholder: incidence rates and comparative trial data pending qualified clinical reviewer sign-off before publication.\n\nGet emergency medical help if you experience a severe allergic reaction, uncontrollable muscle movements, high fever, confusion, or trouble breathing — these may indicate a rare but serious reaction.\n\nWho Should Be Cautious\n\nTell your doctor before starting OLANZPRIME 15 if you have:\n\nDiabetes\nLiver or kidney disease\nHeart conditions\nEpilepsy or seizure history\nHigh cholesterol\nObesity\nGlaucoma\nDementia\nA history of stroke\n\nAvoid alcohol during treatment, as it can intensify drowsiness. Pregnant or breastfeeding women should use this medicine only under close medical supervision, weighing benefits against risks with their doctor.\n\nPrecautions & Storage\nTake exactly as prescribed — never adjust the dose on your own.\nWatch for changes in weight, appetite, or blood sugar during long-term use, and report these to your doctor.\nDon't combine with alcohol or other sedating substances without medical advice.\nStore below 25°C, away from moisture and direct sunlight.\nKeep in the original packaging, out of reach of children.\nComparable Antipsychotic Options\nMedicine Type\tTypical Use Case\tDosage Form Convenience\nStandard Olanzapine Tablets\tSchizophrenia, bipolar disorder\tRequires water to swallow\nOLANZPRIME 15 (MD Tablet)\tSame indications, for patients with swallowing difficulty\tDissolves on tongue, no water needed\nOther Atypical Antipsychotics\tAlternate receptor profiles, physician's choice\tVaries by brand and formulation\n\nNote: Switching between antipsychotic medicines or formulations should only be done under a psychiatrist's guidance.\n\nWhy Choose OLANZPRIME 15?\n\nBeyond its therapeutic role in managing schizophrenia and bipolar disorder, OLANZPRIME 15's mouth-dissolving format addresses a real, practical barrier many psychiatric patients face — reliably swallowing tablets every day. Manufactured to consistent quality standards, it gives psychiatrists a dependable option for patients who need both clinical effectiveness and easier day-to-day administration.\n\nConclusion\n\nLiving with schizophrenia or bipolar disorder often means managing symptoms that affect mood, thought, and daily functioning. OLANZPRIME 15 is formulated to help rebalance the brain chemistry behind these symptoms, in a mouth-dissolving form that simplifies daily dosing for patients who struggle with conventional tablets. Used consistently and under a psychiatrist's care, it supports more stable, manageable day-to-day life. Prescription only – consult your doctor.\n\nFrequently Asked Questions\nWhat is OLANZPRIME 15 used for? It's prescribed for schizophrenia, bipolar disorder, and related psychiatric conditions, under a doctor's guidance.\nHow should I take OLANZPRIME 15? Place it on your tongue, let it dissolve fully, and swallow naturally — follow your doctor's exact dosing instructions.\nDo I need water to take it? No, as a mouth-dissolving tablet it typically doesn't require water.\nCan it cause weight gain? Yes, increased appetite and weight gain are recognized effects in some patients; your doctor may recommend periodic monitoring.\nIs it safe for long-term use? Yes, under a psychiatrist's ongoing supervision with regular follow-up to track effectiveness and side effects.\nCan I stop taking it once I feel better? No — stopping suddenly can cause withdrawal effects or symptom relapse. Any change in dose must go through your doctor.\nDoes OLANZPRIME 15 interact with alcohol? Yes, alcohol can worsen drowsiness and should generally be avoided during treatment.\nIs it safe during pregnancy? It should only be used in pregnancy or breastfeeding under close medical supervision, after discussing risks and benefits with a doctor.\nWhat conditions should I disclose to my doctor before starting? Mention any history of diabetes, liver or kidney disease, heart conditions, epilepsy, high cholesterol, glaucoma, dementia, or stroke.\nCan this medicine affect blood sugar or cholesterol? It can, in some patients, which is why regular monitoring is often recommended during treatment.\nWhat should I do if I notice uncontrollable muscle movements? Seek immediate medical attention, as this can indicate a rare but serious reaction requiring urgent evaluation.\nCan elderly patients take OLANZPRIME 15? Yes, and the mouth-dissolving format is often specifically helpful for elderly patients with swallowing difficulty, but dosing should be carefully individualized by the prescriber.\nHow long does it take to see improvement? Response times vary by individual and condition; your psychiatrist will assess progress over scheduled follow-ups.\nCan OLANZPRIME 15 be taken with other psychiatric medicines? Only under medical supervision, as combinations need careful evaluation for interactions.\nIs a prescription required to purchase OLANZPRIME 15? Yes, it is a Schedule H medicine and can only be dispensed against a valid doctor's prescription.",
"price": 180.0,
"discountamount": 54.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2478,
"imageuri": "https://productimages.withfloats.com/actual/6a5df5ba3a3f53b9d65c6aa2.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a5df5ba3a3f53b9d65c6aa2.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-07-20T10:17:28.721Z",
"updatedon": "2026-07-20T10:24:54.243Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//olanzapine-mouth-dissolving-tablets-15-mg/2478",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "OLANZPRIME 15",
"category": "NEUROLOGYRANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a460bf90c11f3c74a816c87",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "methylprednisolone sodium succinate for injection usp",
"description": "Methylprednisolone Sodium Succinate for Injection USP is a fast-acting corticosteroid administered intravenously or intramuscularly to control severe inflammation, allergic reactions, and autoimmune flare-ups. It works by rapidly suppressing the immune and inflammatory response and is used in hospital or clinical settings for acute conditions such as severe asthma attacks, anaphylaxis, autoimmune disease flares, and spinal cord injury protocols. It is a Schedule H prescription drug administered only under medical supervision.\n\nWhat Is Methylprednisolone Sodium Succinate for Injection USP?\n\nMethylprednisolone Sodium Succinate for Injection USP is a water-soluble, injectable corticosteroid used for rapid control of severe inflammatory, allergic, and autoimmune conditions. It is manufactured to United States Pharmacopeia (USP) standards and is typically administered by a healthcare professional via intravenous (IV) or intramuscular (IM) route when fast, high-potency anti-inflammatory or immunosuppressive action is required — situations where oral steroids act too slowly or oral intake isn't feasible.\n\nHow It Works\n\nMethylprednisolone sodium succinate is a synthetic glucocorticoid that acts rapidly once reconstituted and injected.\n\n\nBinds glucocorticoid receptors – enters cells and binds intracellular receptors that regulate inflammatory gene expression.\nSuppresses inflammatory mediators – reduces production of prostaglandins, leukotrienes, and cytokines responsible for swelling, redness, and pain.\nStabilizes cell membranes – reduces capillary permeability, limiting fluid leakage and tissue swelling at the site of inflammation.\nDampens immune overactivity – suppresses lymphocyte and macrophage activity, calming autoimmune or allergic overreactions.\nDelivers rapid systemic action – because it's water-soluble and given IV/IM, onset of anti-inflammatory effect is significantly faster than oral steroids.\n\n\nClinical Indications\n\nConditionWhy Methylprednisolone Injection Is UsedSevere Allergic Reactions / AnaphylaxisRapidly controls swelling, airway inflammation, and allergic cascadeAcute Asthma Exacerbation / COPD FlareReduces airway inflammation when inhalers alone are insufficientAutoimmune Disease Flares (Lupus, Rheumatoid Arthritis)High-dose pulse therapy to control acute flaresSpinal Cord Injury (acute, under specialist protocol)Used in specific clinical protocols to limit secondary inflammationSevere Dermatologic ReactionsControls widespread inflammatory skin reactionsPost-Transplant / Organ Rejection ManagementUsed as part of immunosuppressive regimens\n\nDosage & Administration\n\nParameterRecommendationTypical Adult Dose10–40 mg IV, may range up to 30 mg/kg in high-dose pulse therapy for specific conditionsRouteIntravenous (IV) injection/infusion or Intramuscular (IM) injectionFrequencyAs directed by the treating physician; often single dose or short tapering courseReconstitutionMust be reconstituted only with the accompanying diluent as per product insert, immediately before useAdministration SettingHospital, clinic, or under direct medical/nursing supervision onlyDurationShort-term acute use unless otherwise directed; long-term use requires specialist monitoring\n\nThis is a Schedule H prescription-only medicine. Dosage must be determined and administered by a qualified healthcare professional.\n\nPrecautions\n\n\nTo be administered only by or under the supervision of a healthcare professional.\nNot for self-administration or home use.\nInform the doctor of any active infections, as corticosteroids can mask symptoms and suppress immune response.\nUse with caution in patients with diabetes, hypertension, peptic ulcer disease, osteoporosis, or psychiatric history.\nAvoid live vaccines during treatment due to immunosuppressive effects.\nPregnant or breastfeeding patients should use only under strict medical guidance.\nAbrupt discontinuation after prolonged use should be avoided; tapering may be required as advised by the physician.\n\n\nPossible Side Effects\n\nMost side effects relate to the drug's systemic corticosteroid action and are monitored by the administering clinician:\n\n\nElevated blood sugar levels\nFluid retention, increased blood pressure\nMood changes, insomnia, or restlessness\nNausea or gastrointestinal discomfort\nIncreased susceptibility to infection\nInjection site reactions\n\n\nSerious side effects requiring immediate medical attention include severe allergic reaction, signs of infection (fever, chills), significant mood or behavioral changes, unusual swelling, or vision disturbances. Because this is administered in a clinical setting, the healthcare team monitors for these actively.\n\nComparison: Methylprednisolone vs. Other Injectable Corticosteroids\n\nDrugRelative PotencyCommon Use CaseRouteMethylprednisolone Sodium SuccinateHighAcute severe inflammation, autoimmune flaresIV/IMHydrocortisone Sodium SuccinateLowerAdrenal insufficiency, milder acute inflammationIV/IMDexamethasone Sodium PhosphateVery HighCerebral edema, severe allergic/inflammatory conditionsIV/IMBetamethasone Sodium PhosphateHighAllergic and inflammatory conditions, fetal lung maturityIV/IMTriamcinolone AcetonideModerate (depot)Localized/intra-articular inflammationIM/Intra-articular\n\nKey Statistics\n\nStatisticData PointSourceOnset of anti-inflammatory action after IV administrationWithin 1–2 hours for measurable effectClinical pharmacology references, USP monographUse in acute severe asthma protocolsRecommended as part of systemic corticosteroid therapy in emergency guidelinesGlobal Initiative for Asthma (GINA) guidelinesHospital use in anaphylaxis managementIncluded as an adjunct in anaphylaxis treatment protocols alongside epinephrineWorld Allergy Organization guidanceHigh-dose pulse therapy applicationUsed in select autoimmune flare protocols under specialist supervisionPublished rheumatology treatment guidelines\n\nExpert Insight\n\n[Insert verified physician or clinical pharmacologist commentary here — Claude has not fabricated a quote. Recommend sourcing a short, attributable statement from a Steris Healthcare medical advisor or a cited clinical guideline before publishing.]\n\nConclusion\n\nMethylprednisolone Sodium Succinate for Injection USP is a high-potency, fast-acting corticosteroid reserved for situations where rapid control of severe inflammation, allergic reaction, or autoimmune flare is essential. Administered only under clinical supervision, it plays a critical role in emergency and hospital-based treatment protocols — from anaphylaxis and acute asthma to autoimmune disease management. As a Schedule H medicine, it must never be self-administered; dosage, route, and duration should always be determined by a qualified physician based on the patient's condition. For pharmacopoeia-grade quality and reliable hospital supply, source this injection through a WHO-GMP certified manufacturer.\n\nPrescription only – consult your doctor.\n\n\nHigh-Ranking FAQs (Google Search & Voice Search Optimized)\n\n1. What is methylprednisolone sodium succinate injection used for?\nIt is used to rapidly control severe inflammation, allergic reactions, and autoimmune flare-ups, such as anaphylaxis, acute asthma attacks, and lupus or rheumatoid arthritis flares. It is administered under medical supervision in hospital or clinical settings.\n\n2. Is methylprednisolone injection a steroid?\nYes, it is a synthetic corticosteroid (glucocorticoid) that works by suppressing inflammatory and immune responses in the body, providing rapid relief in acute, severe conditions.\n\n3. How is methylprednisolone sodium succinate injection given?\nIt is given by a healthcare professional via intravenous (IV) or intramuscular (IM) injection, after being reconstituted with the correct diluent immediately before administration. It is not for self-injection or home use.\n\n4. How fast does methylprednisolone injection start working?\nBecause it is water-soluble and given directly into the bloodstream or muscle, measurable anti-inflammatory effects typically begin within one to two hours of administration.\n\n5. What are the side effects of methylprednisolone injection?\nCommon effects include elevated blood sugar, fluid retention, mood changes, and increased infection risk. These are monitored by the administering healthcare team, and serious reactions are managed promptly in a clinical setting.\n\n6. Is methylprednisolone sodium succinate injection available without a prescription?\nNo. It is a Schedule H prescription-only medicine that must be administered by or under the direct supervision of a qualified healthcare professional.\n\n7. What is the difference between methylprednisolone and dexamethasone injection?\nBoth are injectable corticosteroids, but dexamethasone has a longer duration of action and higher relative potency, while methylprednisolone is often preferred for acute pulse therapy and shorter-acting systemic control. The choice depends on the clinical scenario and physician judgment.\n\n8. Can methylprednisolone injection be used in pregnancy?\nIt may be used in pregnancy only when clearly necessary and under strict medical supervision, as the treating physician will weigh the benefits against potential risks for the specific condition being treated.",
"price": 47.0,
"discountamount": 19.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2465,
"imageuri": "https://productimages.withfloats.com/actual/6a460bfb9f5529389b8b15b8.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a460bfb9f5529389b8b15b8.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-07-02T06:58:01.631Z",
"updatedon": "2026-07-02T06:58:01.631Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//methylprednisolone-sodium-succinate-for-injection-usp/2465",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "METHIDENOSOLE 40 INJ",
"category": "GENERAL RANGE",
"tags": [
"methylprednisolone sodium succinate injection uses",
"methylprednisolone sodium succinate injection uses in hindi",
"methylprednisolone sodium succinate",
"methylprednisolone sodium succinate injection",
"inj methylprednisolone sodium succinate",
"methylprednisolone sodium succinate uses in hindi",
"methylprednisolone sodium succinate for injection",
"methylprednisolone sodium succinate injection usp"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a43bee2d208c802be053f9d",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg",
"description": "Managing type 2 diabetes often requires more than a single medication to achieve long-term blood sugar control. Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg is a triple-combination prescription medicine formulated to help adults with type 2 diabetes maintain healthy glucose levels when diet, exercise, and single-drug therapy are not enough.\n\nThis advanced combination works through three different mechanisms to improve insulin sensitivity, reduce glucose production by the liver, and enhance the body's natural insulin response after meals. Because of its multi-action approach, it is frequently prescribed by healthcare professionals for patients requiring comprehensive glycemic control.\n\nIf you are searching for Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg, this guide covers everything you need to know—including how it works, benefits, dosage information, side effects, precautions, storage, and frequently asked questions.\n\nWhat is Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg?\n\nSitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg is a prescription oral anti-diabetic medicine used to manage Type 2 Diabetes Mellitus. It combines three clinically proven medicines into one convenient tablet to provide better blood sugar management throughout the day.\n\nThe formulation contains:\n\nSitagliptin 100 mg – A DPP-4 inhibitor that increases incretin hormones to improve insulin secretion.\nMetformin Hydrochloride 1000 mg Sustained Release – A biguanide that lowers glucose production by the liver and improves insulin sensitivity.\nPioglitazone 15 mg – A thiazolidinedione that enhances the body's response to insulin.\n\nTogether, these ingredients target multiple causes of high blood sugar, helping patients achieve better diabetes control while reducing the need for multiple separate medications.\n\nHow Does Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg Work?\n\nThis triple-combination tablet works through complementary mechanisms:\n\n1. Sitagliptin\n\nSitagliptin inhibits the DPP-4 enzyme, allowing incretin hormones to remain active longer. These hormones increase insulin release after meals and reduce excess glucagon production.\n\n2. Metformin SR\n\nMetformin Sustained Release decreases glucose production in the liver, reduces intestinal glucose absorption, and improves insulin sensitivity without causing excessive insulin release.\n\n3. Pioglitazone\n\nPioglitazone improves insulin sensitivity in muscle and fat tissues, enabling cells to utilize glucose more effectively.\n\nThe combination helps maintain consistent blood sugar levels throughout the day while lowering both fasting and post-meal glucose.\n\nWhy is This Triple Combination Important?\n\nType 2 diabetes progresses over time, making it difficult for many patients to control blood sugar using a single medication. A triple therapy offers several advantages:\n\nBetter HbA1c reduction\nMultiple mechanisms of action\nReduced insulin resistance\nImproved post-meal glucose control\nLower fasting blood sugar\nSimplified treatment with one tablet\nImproved medication adherence\nReduced need for additional medications\n\nHealthcare providers often prescribe this combination when dual therapy no longer provides adequate glucose control.\n\nKey Benefits of Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg\nExcellent Blood Sugar Control\n\nThe medicine helps reduce both fasting and postprandial blood glucose levels effectively.\n\nTriple Mechanism of Action\n\nEach ingredient targets a different pathway involved in diabetes, resulting in more comprehensive glycemic control.\n\nImproved Insulin Sensitivity\n\nPioglitazone increases insulin responsiveness, helping the body utilize glucose more efficiently.\n\nReduced Liver Glucose Production\n\nMetformin decreases glucose release from the liver, preventing unnecessary increases in blood sugar.\n\nSupports Long-Term Diabetes Management\n\nRegular use, alongside lifestyle modifications, contributes to improved HbA1c levels and reduced diabetes-related complications.\n\nConvenient Once-Daily Regimen\n\nCombining three medicines into a single tablet improves treatment convenience and supports better compliance.\n\nWho May Benefit from This Medicine?\n\nHealthcare professionals may prescribe this medication for adults with Type 2 Diabetes who:\n\nHave uncontrolled blood sugar despite dual therapy\nRequire triple oral anti-diabetic therapy\nHave elevated HbA1c levels\nNeed improved insulin sensitivity\nPrefer fewer tablets in their treatment plan\nAre following dietary and exercise recommendations but require additional glucose control\n\nThis medicine is not intended for Type 1 Diabetes or diabetic ketoacidosis.\n\nHow to Take Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg\n\nAlways follow your physician's instructions.\n\nGeneral recommendations include:\n\nTake once daily or as prescribed.\nSwallow the tablet whole.\nDo not crush, split, or chew the sustained-release tablet.\nTake with food to reduce stomach discomfort.\nTake it at the same time each day.\nContinue exercising and following a diabetic meal plan.\n\nNever stop treatment without consulting your healthcare provider.\n\nPossible Side Effects\n\nLike all prescription medicines, this combination may cause side effects, although not everyone experiences them.\n\nCommon side effects include:\n\nNausea\nStomach discomfort\nDiarrhea\nHeadache\nUpper respiratory infection\nWeight gain\nSwelling of feet or ankles\nMuscle aches\nDizziness\n\nSeek immediate medical attention if you experience:\n\nSevere allergic reaction\nPersistent vomiting\nDifficulty breathing\nSevere abdominal pain\nUnusual fatigue\nYellowing of skin or eyes\nSymptoms of lactic acidosis\nSigns of heart failure, such as rapid weight gain or shortness of breath\nPrecautions Before Using This Medicine\n\nInform your healthcare provider if you have:\n\nKidney disease\nLiver disease\nHeart failure\nBladder cancer history\nPancreatitis\nSevere dehydration\nAlcohol dependence\nVitamin B12 deficiency\nPlanned surgery or imaging with contrast dye\n\nWomen who are pregnant or breastfeeding should use this medicine only under medical supervision.\n\nDrug Interactions\n\nTell your doctor about all medicines you take, including:\n\nInsulin\nSulfonylureas\nDiuretics\nCorticosteroids\nThyroid medicines\nBlood pressure medicines\nRifampicin\nAlcohol\nCimetidine\nCertain antifungal medicines\n\nProper medication review helps minimize interaction risks.\n\nLifestyle Tips for Better Diabetes Control\n\nMedicine works best when combined with healthy lifestyle habits.\n\nRecommended practices include:\n\nFollow a balanced diabetic diet.\nExercise for at least 30 minutes most days.\nMonitor blood sugar regularly.\nMaintain a healthy body weight.\nStay hydrated.\nAvoid smoking.\nLimit alcohol intake.\nGet regular HbA1c tests.\nManage stress effectively.\nAttend routine medical check-ups.\nStorage Instructions\n\nStore the tablets:\n\nBelow 25°C\nIn a cool, dry place\nAway from moisture and direct sunlight\nIn the original packaging\nOut of reach of children and pets\n\nDo not use expired medicine.\n\nWhy Healthcare Professionals Choose This Triple Combination\n\nDoctors frequently recommend Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg because it addresses multiple aspects of diabetes management in a single formulation. By improving insulin secretion, reducing hepatic glucose production, and enhancing insulin sensitivity, it provides comprehensive glycemic control while simplifying treatment. When combined with a healthy lifestyle and regular medical follow-up, it can support long-term diabetes management and help reduce the risk of complications associated with uncontrolled blood sugar.\n\nConclusion\n\nSitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg is an effective prescription medication designed for adults with Type 2 Diabetes Mellitus who require stronger blood sugar management than single or dual therapy can provide. Its triple-action formula offers improved glycemic control, better insulin utilization, and convenient once-daily dosing. While highly effective, it should always be used under the guidance of a qualified healthcare professional, together with a balanced diet, regular physical activity, and routine blood sugar monitoring for the best long-term outcomes.\n\nHigh-Ranking FAQs (Google Search & Voice Search Optimized)\n1. What is Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg used for?\n\nIt is prescribed to help adults with Type 2 Diabetes Mellitus control blood sugar when lifestyle changes and other oral medicines do not provide adequate glycemic control.\n\n2. How does this triple-combination tablet work?\n\nIt combines three medicines that increase insulin release after meals, reduce glucose production by the liver, and improve the body's sensitivity to insulin, resulting in better overall blood sugar control.\n\n3. Can this medicine be taken once daily?\n\nYes. Many patients take it once daily, but the exact dosage and timing should always follow the prescribing doctor's instructions.\n\n4. Should I take this tablet with food?\n\nYes. Taking it with meals helps reduce stomach-related side effects associated with metformin and improves tolerability.\n\n5. Can this medicine cure diabetes?\n\nNo. It helps control blood sugar levels but does not cure Type 2 Diabetes. Long-term treatment, healthy eating, exercise, and regular monitoring remain essential.\n\n6. What should I do if I miss a dose?\n\nTake the missed dose as soon as you remember unless it is nearly time for your next scheduled dose. Do not take two doses together to make up for a missed dose.\n\n7. Can this medicine cause low blood sugar?\n\nOn its own, the risk is relatively low. However, the likelihood increases when it is used with insulin or sulfonylurea medicines, or if meals are skipped.\n\n8. Is this medicine safe for patients with kidney disease?\n\nPatients with kidney impairment require medical evaluation before using this medicine, particularly because metformin may not be suitable in severe kidney dysfunction.\n\n9. Can I drink alcohol while taking this medication?\n\nAlcohol intake should be limited or avoided, as excessive consumption may increase the risk of serious side effects, including lactic acidosis.\n\n10. Who should not use Sitagliptin 100mg Metformin Hydrochloride 1000mg Sustained Release Pioglitazone 15 mg?\n\nIt should not be used without medical advice by individuals with Type 1 Diabetes, diabetic ketoacidosis, severe kidney disease, certain liver conditions, or a history of serious hypersensitivity to any of its ingredients. Always consult your healthcare provider before starting treatment.",
"price": 243.0,
"discountamount": 73.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2462,
"imageuri": "https://productimages.withfloats.com/actual/6a43bee3de301bd6de277db2.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a43bee3de301bd6de277db2.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-06-30T13:04:34Z",
"updatedon": "2026-06-30T13:04:34Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//sitagliptin-100mg-metformin-hydrochloride-1000mg-sustained-release-pioglitazone-15-mg/2462",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "ST GLIPTIN 3D 1000",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a266dd8a533ee2656d39b34",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Latanoprost Opthalmic Solution",
"description": "Latanoprost Ophthalmic Solution – Trusted Eye Drop Treatment for Glaucoma and Ocular Hypertension\nLatanoprost Ophthalmic Solution\n\nIf you are looking for an effective treatment to lower elevated eye pressure and protect your vision, Latanoprost Ophthalmic Solution is one of the most widely prescribed medications for glaucoma and ocular hypertension. Known for its proven efficacy, convenient once-daily dosing, and long-term benefits, Latanoprost helps reduce intraocular pressure (IOP), which is a major risk factor for optic nerve damage and vision loss.\n\nMillions of patients worldwide rely on Latanoprost Ophthalmic Solution to manage chronic eye conditions that can gradually affect eyesight. By improving the natural drainage of fluid from the eye, this medication helps maintain healthy eye pressure levels and supports long-term ocular health.\n\nWhether you have recently been diagnosed with glaucoma or are searching for a reliable eye pressure-lowering treatment, this comprehensive guide will help you understand the uses, benefits, mechanism of action, dosage, side effects, and key advantages of Latanoprost Ophthalmic Solution.\n\nWhat Is Latanoprost Ophthalmic Solution?\n\nLatanoprost Ophthalmic Solution is a prescription eye medication belonging to a class of drugs known as prostaglandin analogs. It is primarily used to reduce elevated intraocular pressure in patients with:\n\nOpen-angle glaucoma\nOcular hypertension\nChronic eye pressure management\nRisk of glaucoma progression\n\nElevated pressure inside the eye can damage the optic nerve over time, leading to permanent vision impairment. Latanoprost Ophthalmic Solution helps prevent this damage by facilitating better fluid drainage from the eye.\n\nBecause of its strong effectiveness and convenient dosing schedule, ophthalmologists often recommend Latanoprost as a first-line treatment for glaucoma management.\n\nHow Latanoprost Ophthalmic Solution Works\n\nThe eye continuously produces a fluid known as aqueous humor. This fluid nourishes the eye and helps maintain its shape. Normally, the fluid drains naturally through specialized pathways.\n\nIn glaucoma and ocular hypertension, fluid drainage becomes inadequate, causing pressure to build up inside the eye.\n\nMechanism of Action\n\nLatanoprost works by:\n\nIncreasing the outflow of aqueous humor from the eye\nEnhancing natural fluid drainage through the uveoscleral pathway\nReducing intraocular pressure effectively\nMaintaining healthier pressure levels throughout the day\n\nBy lowering eye pressure, Latanoprost helps reduce stress on the optic nerve and decreases the risk of progressive vision loss.\n\nIts pressure-lowering effect typically lasts for 24 hours, making once-daily administration highly effective for most patients.\n\nUses of Latanoprost Ophthalmic Solution\n1. Open-Angle Glaucoma\n\nOpen-angle glaucoma is the most common form of glaucoma worldwide. Latanoprost helps lower eye pressure and slow the progression of optic nerve damage.\n\n2. Ocular Hypertension\n\nPatients with elevated intraocular pressure but no significant optic nerve damage can benefit from early pressure reduction to prevent glaucoma development.\n\n3. Long-Term Eye Pressure Control\n\nLatanoprost is commonly prescribed for ongoing management of chronic eye conditions requiring consistent pressure regulation.\n\n4. Vision Preservation\n\nBy reducing pressure within the eye, Latanoprost helps protect vision and maintain overall eye health over time.\n\n5. Prevention of Glaucoma Progression\n\nMaintaining controlled intraocular pressure significantly lowers the likelihood of disease advancement and associated vision loss.\n\nKey Benefits of Latanoprost Ophthalmic Solution\nEffective Intraocular Pressure Reduction\n\nLatanoprost is highly effective in lowering elevated eye pressure and maintaining stable control.\n\nOnce-Daily Dosing\n\nThe medication typically requires only one application per day, making treatment simple and convenient.\n\nLong-Lasting Action\n\nA single dose can provide pressure-lowering effects for up to 24 hours.\n\nSupports Optic Nerve Protection\n\nReducing eye pressure helps safeguard the optic nerve from long-term damage.\n\nImproved Treatment Compliance\n\nThe easy dosing schedule encourages consistent medication use and better treatment outcomes.\n\nWidely Trusted by Eye Specialists\n\nLatanoprost has been extensively studied and remains one of the most prescribed glaucoma medications globally.\n\nHelps Preserve Vision\n\nRegular use contributes to long-term visual health and reduces the risk of glaucoma-related blindness.\n\nWho Can Benefit from Latanoprost Ophthalmic Solution?\n\nLatanoprost Ophthalmic Solution may be suitable for:\n\nAdults diagnosed with open-angle glaucoma\nPatients with ocular hypertension\nIndividuals requiring long-term eye pressure management\nPatients seeking convenient once-daily therapy\nIndividuals at risk of optic nerve damage\nPatients requiring preventive glaucoma treatment\n\nYour ophthalmologist will determine whether Latanoprost is appropriate based on your eye condition and medical history.\n\nWhy Buyers Choose Latanoprost Ophthalmic Solution\n\nWhen purchasing glaucoma medication, patients prioritize effectiveness, convenience, and safety. Latanoprost Ophthalmic Solution consistently meets these expectations.\n\nBuyer Intent Advantages\nProven glaucoma treatment\nTrusted by ophthalmologists worldwide\nConvenient once-daily application\nEffective pressure reduction\nLong-term vision protection\nEasy incorporation into daily routines\nSuitable for chronic use\nClinically established safety profile\n\nThese advantages make Latanoprost Ophthalmic Solution one of the most preferred choices for glaucoma management.\n\nHow to Use Latanoprost Ophthalmic Solution\n\nFor best results, use the medication exactly as prescribed by your healthcare provider.\n\nGeneral Directions\nWash your hands thoroughly.\nShake the bottle if instructed.\nTilt your head backward.\nPull down the lower eyelid gently.\nInstill one drop into the affected eye.\nClose your eyes for one to two minutes.\nAvoid touching the dropper tip to any surface.\nReplace the cap securely after use.\n\nLatanoprost is usually administered once daily in the evening unless otherwise directed by your ophthalmologist.\n\nImportant Precautions\n\nBefore using Latanoprost Ophthalmic Solution, inform your healthcare provider if you have:\n\nEye inflammation\nEye infections\nHistory of eye surgery\nMacular edema\nContact lens use\nSevere allergies\nOther ongoing eye conditions\n\nRegular eye examinations are important to monitor treatment effectiveness and eye health.\n\nPossible Side Effects of Latanoprost Ophthalmic Solution\n\nLike all medications, Latanoprost may cause side effects in some individuals.\n\nCommon Side Effects\nEye redness\nMild irritation\nBurning sensation\nItching\nTemporary blurred vision\nIncreased tearing\nDry eye sensation\nLong-Term Cosmetic Changes\n\nSome users may experience:\n\nDarkening of the iris color\nIncreased eyelash growth\nThickening of eyelashes\nDarkening of eyelid skin\n\nThese changes usually occur gradually and may become permanent with prolonged use.\n\nLess Common Side Effects\nEye pain\nSensitivity to light\nSwelling around the eye\nVision disturbances\n\nSeek immediate medical attention if severe allergic reactions or significant vision changes occur.\n\nStorage Instructions\n\nProper storage helps maintain medication quality and effectiveness.\n\nRecommended Storage Guidelines\nStore at the temperature recommended on the product label.\nKeep away from direct sunlight.\nProtect from excessive heat.\nKeep the bottle tightly closed when not in use.\nDo not use after the expiration date.\nKeep out of reach of children.\n\nAlways follow manufacturer-specific storage instructions.\n\nFrequently Asked Questions\nCan Latanoprost cure glaucoma?\n\nNo. Latanoprost does not cure glaucoma but helps control eye pressure and slow disease progression.\n\nHow quickly does it lower eye pressure?\n\nPressure reduction typically begins within a few hours of administration, with maximum effects developing over continued use.\n\nCan it be used long term?\n\nYes. Latanoprost is commonly prescribed for long-term management of glaucoma and ocular hypertension.\n\nWhat happens if I miss a dose?\n\nTake the next scheduled dose as directed. Do not use extra drops to compensate for a missed application.\n\nCan contact lens users use Latanoprost?\n\nYes, but contact lenses may need to be removed before application and reinserted after the recommended waiting period advised by your doctor.\n\nConclusion\n\nLatanoprost Ophthalmic Solution is a highly effective and widely trusted treatment for reducing elevated intraocular pressure associated with glaucoma and ocular hypertension. By enhancing the natural drainage of fluid from the eye, it helps maintain healthy eye pressure levels, protect the optic nerve, and preserve long-term vision.\n\nIts once-daily dosing, proven clinical effectiveness, and established safety profile make it a preferred choice among ophthalmologists and patients alike. Whether you are newly diagnosed with glaucoma or seeking reliable long-term eye pressure management, Latanoprost Ophthalmic Solution offers a dependable solution for protecting your eyesight and supporting overall ocular health.",
"price": 390.0,
"discountamount": 117.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2442,
"imageuri": "https://productimages.withfloats.com/actual/6a266ddeac30b85f9a4b1407.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a266ddeac30b85f9a4b1407.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-06-08T07:23:04.74Z",
"updatedon": "2026-06-08T07:23:04.74Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//latanoprost-opthalmic-solution/2442",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "CIPVISION LOPESTAL",
"category": "Opthalmology Range",
"tags": [
"latanoprost opthalmic solution",
"latanoprost opthalmic",
"latanoprost ophthalmic solution 0.005",
"latanoprost ophthalmic solution 0.005 price",
"latanoprost 0.005 eye drops price in india",
"latanoprost 0.005 eye drops price",
"latanoprost ophthalmic solution uses",
"latanoprost ophthalmic solution uses",
"Latanoprost Opthalmic Solution in hindi"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}